ArticleHealth science reports2025
Prevalence and Distribution of HPV Genotypes in Patients With Genital Warts: A Cross-Sectional Study From South of Iran.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
- Prevalence and Distribution of HPV Genotypes in Patients With Genital Warts: A Cross-Sectional Study From South of Iran.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Human papillomavirus (HPV), the most prevalent sexually transmitted infection, causes genital warts primarily through low-risk genotypes. However, the presence of high-risk genotypes highlights the need for genotype-specific surveillance to guide clinical management and prevention strategies. Methods: This cross-sectional study aimed to investigate the prevalence and distribution of HPV genotypes among patients diagnosed with genital warts at Shahid Faghihi Hospital in Shiraz, Iran, from 2017 to 2024. HPV genotyping was performed using PCR, and statistical analyses were used to evaluate associations between genotypes, sex, and age groups. Results: The study included 291 patients, predominantly female (85.2%) and aged 20-34 years (58.08%). Low-risk HPV genotypes accounted for 91.35% of cases, while high-risk genotypes HPV-16 and HPV-18 were detected in 6.92% and 1.73% of cases, respectively. A significant association was observed between sex and genotype distribution ( Conclusion: Low-risk HPV genotypes were most common in genital warts (91.35%), and HPV genotype distribution was significantly different between female and male patients. These findings emphasize the need for HPV vaccination programs and routine genotyping to guide clinical management in Iran's population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.